Novel METTL3 Modulators for Treating Acute Myeloid Leukemia (AML)
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTNovel METTL3 Modulators for Treating Acute Myeloid Leukemia (AML)Ram W. Sabnis*Ram W. SabnisSmith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States*E-mail: [email protected]More by Ram W. Sabnishttps://orcid.org/0000-0001-7289-0581Cite this: ACS Med. Chem. Lett. 2021, 12, 7, 1061–1062Publication Date (Web):June 23, 2021Publication History...
Paper Details
Title
Novel METTL3 Modulators for Treating Acute Myeloid Leukemia (AML)
Published Date
Jun 23, 2021
Volume
12
Issue
7
Pages
1061 - 1062
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History